STEPHANIE NEWMAN: Open Payments
NPI 1093181794 · FAYETTEVILLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$547 in 24 payments from 17 companies in 2025. Trend: 2023 $675 · 2024 $533 · 2025 $547
Food & beverage: $462Education: $85
| Company | Payments | Amount |
|---|---|---|
| PharmaEssentia USA Corporation | 1 | $121 |
| Gilead Sciences, Inc. | 1 | $85 |
| Janssen Biotech, Inc. | 4 | $62 |
| Daiichi Sankyo Inc. | 2 | $32 |
| Iovance Biotherapeutics, Inc. | 2 | $30 |
| JAZZ PHARMACEUTICALS INC. | 2 | $27 |
| PFIZER INC. | 2 | $27 |
| Ipsen Biopharmaceuticals, Inc | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $19 |
Products named: BESREMI, Trodelvy, CARVYKTI, Enhertu, Amtagvi, ELREXFIO, Onivyde, LYNPARZA.
Industry payments across AR — which companies pay providers there.
